United Therapeutics Corporation Insider Trading

UTHR

Last 12 months

Insiders sold $1.44B and bought nothing on the open market.

99% of the selling was scheduled in advance under 10b5-1 plans. Director Louis W Sullivan sold $3.05M on Dec 22, 2025, 65% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2023.

Net open-market

−$1.44B

0 buys · 291 sales

Under a 10b5-1 plan

99%

of the value sold

Insiders who bought / sold

0 / 12

executives and directors

Last open-market buy

May 2023

May 3, 2023

Get an email when UTHR's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 3	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 8 parts	9,500	$601.92 average	$5.72M	2.5%	Form 4
Nov 2	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 7 parts	9,500	$596.22 average	$5.66M	2.5%	Form 4
Oct 30	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 13 parts	9,500	$600.09 average	$5.7M	2.5%	Form 4
Oct 29	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 9 parts	9,500	$594.78 average	$5.65M	2.5%	Form 4
Oct 28	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 6 parts	9,500	$585.49 average	$5.56M	2.5%	Form 4
Oct 27	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 11 parts	9,500	$587.73 average	$5.58M	2.5%	Form 4
Oct 26	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 8 parts	9,500	$588.64 average	$5.59M	2.5%	Form 4
Oct 23	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 11 parts	9,500	$582.76 average	$5.54M	2.5%	Form 4
Oct 22	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 21 parts	9,500	$583.38 average	$5.54M	2.5%	Form 4
Oct 21	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 14 parts	9,500	$560.07 average	$5.32M	2.5%	Form 4
Oct 20	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 17 parts	9,500	$553.87 average	$5.26M	2.5%	Form 4
Oct 19	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 19 parts	9,500	$543.32 average	$5.16M	2.5%	Form 4
Oct 16	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 13 parts	9,500	$534.66 average	$5.08M	2.5%	Form 4
Oct 15	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 12 parts	9,500	$546.65 average	$5.19M	2.5%	Form 4
Oct 15	Paul A Mahon EVP & General Counsel	Sold10b5-1 plan 6 parts	8,300	$544.30 average	$4.52M	16%	Form 4
Oct 14	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 16 parts	9,500	$539.99 average	$5.13M	2.5%	Form 4
Oct 13	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 10 parts	9,500	$545.52 average	$5.18M	2.5%	Form 4
Oct 12	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 7 parts	9,500	$550.70 average	$5.23M	2.5%	Form 4
Oct 9	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 17 parts	9,500	$544.94 average	$5.18M	2.5%	Form 4
Oct 8	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 16 parts	9,500	$534.31 average	$5.08M	2.5%	Form 4
Oct 7	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 14 parts	9,500	$548.95 average	$5.22M	2.5%	Form 4
Oct 6	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 17 parts	9,500	$538.67 average	$5.12M	2.5%	Form 4
Oct 5	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 11 parts	9,500	$541.64 average	$5.15M	2.5%	Form 4
Oct 2	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 23 parts	9,500	$549.37 average	$5.22M	2.5%	Form 4
Oct 1	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 19 parts	9,500	$576.47 average	$5.48M	2.5%	Form 4
Oct 1	Paul A Mahon EVP & General Counsel	Sold10b5-1 plan 10 parts	8,300	$564.95 average	$4.69M	16%	Form 4
Sep 30	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 8 parts	1,920	$550.22 average	$1.06M	0.5%	Form 4
Sep 30	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 24 parts	7,580	$517.97 average	$3.93M	2.0%	Form 4
Sep 29	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 12 parts	9,500	$477.42 average	$4.54M	2.5%	Form 4
Sep 28	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 14 parts	9,500	$480.85 average	$4.57M	2.5%	Form 4
Sep 25	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 9 parts	9,500	$476.17 average	$4.52M	2.5%	Form 4
Sep 24	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 11 parts	9,500	$473.55 average	$4.5M	2.5%	Form 4
Sep 23	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 12 parts	9,500	$491.57 average	$4.67M	2.5%	Form 4
Sep 22	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 10 parts	9,500	$494.83 average	$4.7M	2.5%	Form 4
Sep 21	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 5 parts	9,500	$494.55 average	$4.7M	2.5%	Form 4
Sep 18	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 6 parts	9,500	$494.79 average	$4.7M	2.5%	Form 4
Sep 17	Paul A Mahon EVP & General Counsel	Sold10b5-1 plan 7 parts	8,300	$497.54 average	$4.13M	16%	Form 4
Sep 17	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 9 parts	9,500	$496.06 average	$4.71M	2.5%	Form 4
Sep 16	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 8 parts	9,500	$501.39 average	$4.76M	2.5%	Form 4
Sep 15	Martine A Rothblatt Chairperson & CEO	Sold10b5-1 plan 6 parts	9,500	$501.59 average	$4.77M	2.5%	Form 4

Nov 310b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $601.92
$5.72M
2.5% of stake
Nov 210b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $596.22
$5.66M
2.5% of stake
Oct 3010b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $600.09
$5.7M
2.5% of stake
Oct 2910b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $594.78
$5.65M
2.5% of stake
Oct 2810b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $585.49
$5.56M
2.5% of stake
Oct 2710b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $587.73
$5.58M
2.5% of stake
Oct 2610b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $588.64
$5.59M
2.5% of stake
Oct 2310b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $582.76
$5.54M
2.5% of stake
Oct 2210b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $583.38
$5.54M
2.5% of stake
Oct 2110b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $560.07
$5.32M
2.5% of stake
Oct 2010b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $553.87
$5.26M
2.5% of stake
Oct 1910b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $543.32
$5.16M
2.5% of stake
Oct 1610b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $534.66
$5.08M
2.5% of stake
Oct 1510b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $546.65
$5.19M
2.5% of stake
Oct 1510b5-1 plan
Paul A Mahon
EVP & General Counsel · sold 8,300 at avg $544.30
$4.52M
16% of stake
Oct 1410b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $539.99
$5.13M
2.5% of stake
Oct 1310b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $545.52
$5.18M
2.5% of stake
Oct 1210b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $550.70
$5.23M
2.5% of stake
Oct 910b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $544.94
$5.18M
2.5% of stake
Oct 810b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $534.31
$5.08M
2.5% of stake
Oct 710b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $548.95
$5.22M
2.5% of stake
Oct 610b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $538.67
$5.12M
2.5% of stake
Oct 510b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $541.64
$5.15M
2.5% of stake
Oct 210b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $549.37
$5.22M
2.5% of stake
Oct 110b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $576.47
$5.48M
2.5% of stake
Oct 110b5-1 plan
Paul A Mahon
EVP & General Counsel · sold 8,300 at avg $564.95
$4.69M
16% of stake
Sep 3010b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 1,920 at avg $550.22
$1.06M
0.5% of stake
Sep 3010b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 7,580 at avg $517.97
$3.93M
2.0% of stake
Sep 2910b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $477.42
$4.54M
2.5% of stake
Sep 2810b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $480.85
$4.57M
2.5% of stake
Sep 2510b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $476.17
$4.52M
2.5% of stake
Sep 2410b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $473.55
$4.5M
2.5% of stake
Sep 2310b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $491.57
$4.67M
2.5% of stake
Sep 2210b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $494.83
$4.7M
2.5% of stake
Sep 2110b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $494.55
$4.7M
2.5% of stake
Sep 1810b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $494.79
$4.7M
2.5% of stake
Sep 1710b5-1 plan
Paul A Mahon
EVP & General Counsel · sold 8,300 at avg $497.54
$4.13M
16% of stake
Sep 1710b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $496.06
$4.71M
2.5% of stake
Sep 1610b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $501.39
$4.76M
2.5% of stake
Sep 1510b5-1 plan
Martine A Rothblatt
Chairperson & CEO · sold 9,500 at avg $501.59
$4.77M
2.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch UTHR, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with UTHR

CompareIntrinsic value

AMRXAmneal Pharmaceuticals Inc.

$19.95-1.29%57

BMRNBiomarin Pharmaceutical Inc.

$57.13+2.64%47

ALNYAlnylam Pharmaceuticals Inc

$161.08+0.74%81

RPRXRoyalty Pharma plc

$67.56+1.75%19

PRGOPerrigo Company plc

$15.83+0.83%17

SRPTSarepta Therapeutics Inc.

$18.99+2.43%51

JAZZJazz Pharmaceuticals plc

$234.66+2.14%58

ALKSAlkermes plc

$45.90+0.46%36

Held by ETFs

UTHR is in 242 US ETFs. The largest of them, with UTHR's weight in each:

Spot a number that looks wrong? Check it in UTHR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing UTHR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.